Rationale for Using Ischemic Stroke Models, Y. Wang-Fischer and L. Koetzner
Animal Models of Ischemic Stroke: A Historical Survey, Y. Wang-Fischer and L. Koetzner
Anatomy and Cerebral Circulation of the Rat, Y. Wang-Fischer, R. Prado, and L. Koetzner
Which Animal to Choose?, Y. Wang-Fischer, B.D. Watson, and L. Koetzner
Which Model to Use?, Y. Wang-Fischer and L. Koetzner
Failure Is the Mother of Success: Why Neuroprotective Therapies That Work in Laboratories Fail in Clinical Trials, L. Koetzner and Y. Wang-Fischer
Anesthesia of Laboratory Rats, Y. Wang-Fischer and L. Koetzner
General Principles of Microsurgery on Animals, Y. Wang-Fischer, B. Watson, and L. Koetzner
Microsurgical Instruments for Stroke Studies, Y. Wang-Fischer and L. Koetzner
Postoperative Care, Y. Wang-Fischer and L. Koetzner
Surgery Procedure for Distal Middle Cerebral Artery Occlusion Model, Y. Wang-Fischer and L. Koetzner
Surgical Models of Stroke Induced by Intraluminal Filament Implantation, Y. Wang-Fischer, A.A. Divani, R. Prado, and L. Koetzner
Embolic Stroke Models, Y. Wang-Fischer, A.A. Divani, and L. Koetzner
Photochemically Based Models of Focal Experimental Thrombotic Stroke in Rodents, B.D. Watson and R. Prado
Induction of Asphyxia Cardiac Arrest in a Rat as a Model of Global Cerebral Ischemia, K.R. Dave, R. Prado, and M.A. Perez-Pinzon
Four-Vessel Occlusion Stroke Model in Rats, Y. Wang-Fischer and L. Koetzner
Brain Hemorrhage Models in Rodents, Y. Wang-Fischer and L. Koetzner
Endpoints for Stroke Studies, Y. Wang-Fischer and L. Koetzner
Tissue Staining Techniques for Stroke Studies, Y. Wang-Fischer and L. Koetzner
Protocol for Brain Vessel Corrosion Casting and Embedding, A.A. Divani and Y. Wang-Fischer
Magnetic Resonance Imaging in Stroke Study, Y. Wang-Fischer and S. Sen
Administration of Substances and Sampling, Y. Wang-Fischer and J. McCool
Study Design in Animal Models of Stroke, Y. Wang-Fischer and L. Koetzner
Common Biochemical and Physiological Parameters in Rats, Y. Wang-Fischer and L. Koetzner
Biography
Yanlin Wang-Fischer, M.D., Ph.D., is a neuropharmacologist. She has worked in the pharmaceutical industry and academic environment for many years. Dr. Wang-Fischer earned her bachelor’s degree and doctor of medicine at Hunan Medical University, Changsha, China. Following clinical fellowship training in cardiovascular and metabolic diseases at Hunan Medical University, where she became an attending physician, she earned her Ph.D. in 1994. She completed her postdoctoral fellowship training at the School of Medicine at Laval University and at Boston University. Dr. Wang-Fischer joined the Howard Hughes Medical Institute at Yale University, New Haven, Connecticut, in 2000. She has contributed to several projects related to animal models and surgeries and produced an instructional video on studies of animals in vivo for new trainees. In 2002, Dr. Wang-Fischer joined the team of neurological disorders at Johnson & Johnson PRD, Raritan, New Jersey. She led projects based on different animal models to discover new drugs for treatment of stroke and neurological diseases. In 2006, Dr. Wang-Fischer joined Palatin Technologies and oversees projects on nasal and cerebral drug delivery. She has developed a novel technique to quickly assess nasal tolerance. Dr. Wang-Fischer has published more than 40 scientific articles in prestigious medical journals. Her current interests include neurological, cardiovascular, metabolic, and inflammatory diseases, mainly concerned with physiology and pharmacology in vivo.
